Sex, racial, and ethnic disparities in United States liver transplantation clinical trials
Our analysis indicates that women, African Americans, and Hispanic individuals are underrepresented in LT clinical trials compared to the general United States population. These results highlight the need for regulatory initiatives aimed at enhancing the inclusion of historically marginalized racial and ethnic groups in clinical research.
Authors
- Ali Khalifa (ORCID: https://orcid.org/0000-0002-1351-9341)
- Raffi Karagozian
- John H. Helzberg
- Dushyant Singh Dahiya (ORCID: https://orcid.org/0000-0002-8544-9039)
- Zeeshan Khalid
- Sharifeh Almasaid (ORCID: https://orcid.org/0000-0002-7611-1191)
- Laith Numan (ORCID: https://orcid.org/0000-0001-6162-2821)
- Razan Aburumman (ORCID: https://orcid.org/0000-0003-1559-7893)
- Yassine Kilani (ORCID: https://orcid.org/0000-0002-2888-160X)
- Saqr Alsakarneh (ORCID: https://orcid.org/0000-0002-8776-2176)
Institutions
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.4254/wjh.v17.i9.110384
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00